Log in to save to my catalogue

The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-dia...

The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-dia...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2260483274

The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-diabetic chronic kidney disease

About this item

Full title

The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-diabetic chronic kidney disease

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-07, Vol.14 (7), p.e0220158-e0220158

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Adiponectin is the most abundant circulating adipokine, and it has insulin-sensitizing and anti-inflammatory properties. Although it has been speculated that kidney function decline associated with elevated adiponectin is attributable to decreased renal clearance and compensatory responses to adiponectin resistance, it is unclear how elevated adipo...

Alternative Titles

Full title

The association of adiponectin with metabolic syndrome and clinical outcome in patients with non-diabetic chronic kidney disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2260483274

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2260483274

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0220158

How to access this item